tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

Compare companies

Six facts from the filings for each company in a group, then what each says about a topic in its latest 10-K.

Compare
1 · Companies

Health care: the same six facts for each company

From each company's latest 10-K, 10-Q, Form 4s and the superinvestors' 13Fs
12 of 60 shown
CI Cigna
Sales growth
+11%
Net margin
2.1%
Debt / equity
0.68
Accounting items to read
0 of 4
Insider buys, 90 days
0
Big investors holding
0
UNH UnitedHealth Group
Sales growth
+12%
Net margin
3.5%
Debt / equity
0.71
Accounting items to read
1 of 5
Insider buys, 90 days
0
Big investors holding
0
CVS CVS Health
Sales growth
+7.8%
Net margin
2.6%
Debt / equity
0.75
Accounting items to read
0 of 6
Insider buys, 90 days
1
Big investors holding
0
MCK McKesson
Sales growth
+12%
Net margin
1.1%
Debt / equity
-
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
COR Cencora
Sales growth
+9.3%
Net margin
0.8%
Debt / equity
3.93
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
CAH Cardinal Health
Sales growth
+14%
Net margin
0.7%
Debt / equity
-
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
CNC Centene Corporation
Sales growth
+19%
Net margin
0.7%
Debt / equity
0.70
Accounting items to read
1 of 3
Insider buys, 90 days
0
Big investors holding
0
ELV Elevance Health
Sales growth
+12%
Net margin
2.5%
Debt / equity
0.69
Accounting items to read
0 of 3
Insider buys, 90 days
0
Big investors holding
0
HUM Humana
Sales growth
+10%
Net margin
0.8%
Debt / equity
0.66
Accounting items to read
1 of 4
Insider buys, 90 days
0
Big investors holding
0
JNJ Johnson & Johnson
Sales growth
+6.0%
Net margin
16%
Debt / equity
0.55
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
LLY Eli Lilly
Sales growth
+45%
Net margin
32%
Debt / equity
1.23
Accounting items to read
3 of 6
Insider buys, 90 days
0
Big investors holding
0
HCA HCA Healthcare
Sales growth
+7.1%
Net margin
8.6%
Debt / equity
-
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
All 60 companies in Health care
MRK Merck & Co.
Sales growth
+1.3%
Net margin
3.6%
Debt / equity
1.20
Accounting items to read
2 of 6
Insider buys, 90 days
0
Big investors holding
0
ABBV AbbVie
Sales growth
+8.6%
Net margin
16%
Debt / equity
-
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
PFE Pfizer
Sales growth
-1.6%
Net margin
6.3%
Debt / equity
0.70
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
BMY Bristol Myers Squibb
Sales growth
-0.2%
Net margin
18%
Debt / equity
1.86
Accounting items to read
0 of 5
Insider buys, 90 days
0
Big investors holding
0
ABT Abbott Laboratories
Sales growth
+5.7%
Net margin
9.7%
Debt / equity
0.61
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
TMO Thermo Fisher Scientific
Sales growth
+3.9%
Net margin
15%
Debt / equity
0.79
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
AMGN Amgen
Sales growth
+10.0%
Net margin
24%
Debt / equity
3.76
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
MDT Medtronic
Sales growth
+8.4%
Net margin
14%
Debt / equity
0.56
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
GILD Gilead Sciences
Sales growth
+2.4%
Net margin
-12%
Debt / equity
2.01
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
SYK Stryker Corporation
Sales growth
+11%
Net margin
14%
Debt / equity
0.61
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
DHR Danaher Corporation
Sales growth
+2.9%
Net margin
17%
Debt / equity
0.53
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
BDX Becton Dickinson
Sales growth
+8.2%
Net margin
4.2%
Debt / equity
0.69
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
GEHC GE HealthCare
Sales growth
+4.8%
Net margin
10.0%
Debt / equity
0.86
Accounting items to read
2 of 5
Insider buys, 90 days
0
Big investors holding
0
BSX Boston Scientific
Sales growth
+20%
Net margin
17%
Debt / equity
0.47
Accounting items to read
1 of 6
Insider buys, 90 days
1
Big investors holding
0
UHS Universal Health Services
Sales growth
+9.7%
Net margin
8.0%
Debt / equity
0.75
Accounting items to read
0 of 5
Insider buys, 90 days
0
Big investors holding
0
IQV IQVIA
Sales growth
+5.9%
Net margin
8.1%
Debt / equity
2.41
Accounting items to read
0 of 5
Insider buys, 90 days
0
Big investors holding
0
REGN Regeneron Pharmaceuticals
Sales growth
+1.0%
Net margin
29%
Debt / equity
0.06
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
VTRS Viatris
Sales growth
-3.0%
Net margin
-4.1%
Debt / equity
0.97
Accounting items to read
0 of 5
Insider buys, 90 days
0
Big investors holding
0
LH Labcorp
Sales growth
+7.2%
Net margin
6.9%
Debt / equity
0.66
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
DVA DaVita
Sales growth
+6.5%
Net margin
6.5%
Debt / equity
-
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
HSIC Henry Schein
Sales growth
+4.0%
Net margin
3.1%
Debt / equity
1.12
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
VRTX Vertex Pharmaceuticals
Sales growth
+8.9%
Net margin
31%
Debt / equity
0.22
Accounting items to read
4 of 6
Insider buys, 90 days
0
Big investors holding
0
DGX Quest Diagnostics
Sales growth
+12%
Net margin
9.5%
Debt / equity
0.73
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
BAX Baxter International
Sales growth
+5.7%
Net margin
-6.2%
Debt / equity
1.45
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
ISRG Intuitive Surgical
Sales growth
+21%
Net margin
26%
Debt / equity
-
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
BIIB Biogen
Sales growth
+2.2%
Net margin
3.4%
Debt / equity
0.39
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
ZTS Zoetis
Sales growth
+2.3%
Net margin
26%
Debt / equity
2.74
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
ZBH Zimmer Biomet
Sales growth
+7.2%
Net margin
9.0%
Debt / equity
0.59
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
SOLV Solventum
Sales growth
+0.9%
Net margin
1.9%
Debt / equity
0.95
Accounting items to read
2 of 6
Insider buys, 90 days
0
Big investors holding
0
A Agilent Technologies
Sales growth
+6.7%
Net margin
20%
Debt / equity
0.54
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
EW Edwards Lifesciences
Sales growth
+12%
Net margin
15%
Debt / equity
0.06
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
STE Steris
Sales growth
+8.7%
Net margin
13%
Debt / equity
0.26
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
INCY Incyte
Sales growth
+21%
Net margin
6.7%
Debt / equity
-
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
RMD ResMed
Sales growth
+9.9%
Net margin
28%
Debt / equity
0.07
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
WAT Waters Corporation
Sales growth
+7.0%
Net margin
1.8%
Debt / equity
0.34
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
DXCM Dexcom
Sales growth
+16%
Net margin
19%
Debt / equity
-
Accounting items to read
2 of 6
Insider buys, 90 days
0
Big investors holding
0
IDXX Idexx Laboratories
Sales growth
+10%
Net margin
25%
Debt / equity
0.20
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
ILMN Illumina, Inc.
Sales growth
-0.7%
Net margin
20%
Debt / equity
0.57
Accounting items to read
2 of 6
Insider buys, 90 days
0
Big investors holding
0
COO Cooper Companies
Sales growth
+5.1%
Net margin
13%
Debt / equity
0.31
Accounting items to read
1 of 6
Insider buys, 90 days
5
Big investors holding
0
MTD Mettler Toledo
Sales growth
+4.0%
Net margin
22%
Debt / equity
-
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
ALGN Align Technology
Sales growth
+0.9%
Net margin
12%
Debt / equity
-
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
CRL Charles River Laboratories
Sales growth
-0.9%
Net margin
1.0%
Debt / equity
0.76
Accounting items to read
0 of 6
Insider buys, 90 days
1
Big investors holding
0
VEEV Veeva Systems
Sales growth
+16%
Net margin
29%
Debt / equity
-
Accounting items to read
0 of 5
Insider buys, 90 days
0
Big investors holding
0
WST West Pharmaceutical Services
Sales growth
+6.3%
Net margin
19%
Debt / equity
0.07
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
PODD Insulet Corporation
Sales growth
+31%
Net margin
13%
Debt / equity
0.61
Accounting items to read
1 of 4
Insider buys, 90 days
1
Big investors holding
0
RVTY Revvity
Sales growth
+3.7%
Net margin
8.6%
Debt / equity
0.36
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
MRNA Moderna
Sales growth
-40%
Net margin
-110%
Debt / equity
0.09
Accounting items to read
1 of 6
Insider buys, 90 days
0
Big investors holding
0
TECH Bio-Techne
Sales growth
-0.4%
Net margin
14%
Debt / equity
0.18
Accounting items to read
0 of 6
Insider buys, 90 days
0
Big investors holding
0
2 · By topic

Crypto: paragraphs that mention it

Risk Factors paragraphs in each company's latest 10-K · bar = this year · line = last year
10-K Item 1A
CI 1 vs 1 VEEV 1 vs 1 A 0 vs 0 ABBV 0 vs 0 ABT 0 vs 0 ACAD 0 vs 0 ACHC 0 vs 0 ADMA 0 vs 0 ADUS 0 vs 0 AGIO 0 vs 0 ALGN 0 vs 0 ALKS 0 vs 0 ALNY 0 vs 0 AMGN 0 vs 0 AMRX 0 vs 0 AXSM 0 vs 0 BAX 0 vs 0 BBIO 0 vs 0 BCRX 0 vs 0 BDX 0 vs 0 BEAM 0 vs 0 BHC 0 vs 0 BIIB 0 vs 0 BKD 0 vs 0 BMRN 0 vs 0 BMY 0 vs 0 BSX 0 vs 0 BTSG 0 vs 0 CAH 0 vs 0 CAI no 10-K CGON no 10-K CHE no 10-K CNC 0 vs 0 CON no 10-K COO 0 vs 0 COR 0 vs 0 CORT no 10-K CRL 0 vs 0 CRSP no 10-K CVS 0 vs 0 CYTK no 10-K DGX 0 vs 0 DHR 0 vs 0 DVA 0 vs 0 DXCM 0 vs 0 EHC no 10-K ELAN no 10-K ELV 0 vs 0 ENOV no 10-K ENSG no 10-K EW 0 vs 0 EXEL no 10-K GEHC 0 vs 0 GH no 10-K GILD 0 vs 0 GKOS no 10-K GMED no 10-K GRAL no 10-K HAE no 10-K HALO no 10-K HCA 0 vs 0 HIMS no 10-K HSIC 0 vs 0 HUM 0 vs 0 ICUI no 10-K IDXX 0 vs 0 IDYA no 10-K ILMN 0 vs 0 INCY 0 vs 0 INSM no 10-K INSP no 10-K IONS no 10-K IQV 0 vs 0 IRTC no 10-K ISRG 0 vs 0 ITGR no 10-K JAZZ no 10-K JNJ 0 vs 0 KRYS no 10-K KYMR no 10-K LGND no 10-K LH 0 vs 0 LIVN no 10-K LLY 0 vs 0 LMAT no 10-K LNTH no 10-K MCK 0 vs 0 MDGL no 10-K MDLN no 10-K MDT 0 vs 0 MEDP no 10-K MIRM no 10-K MMSI no 10-K MRK 0 vs 0 MRNA 0 vs 0 MSA no 10-K MTD 0 vs 0 NBIX no 10-K NTRA no 10-K NVST no 10-K OCUL no 10-K OGN no 10-K ONC no 10-K OPCH no 10-K PBH no 10-K PCVX no 10-K PEN no 10-K PFE 0 vs 0 PGNY no 10-K PODD 0 vs 0 PRCT no 10-K PRGO no 10-K PRVA no 10-K PTGX no 10-K QDEL no 10-K RARE no 10-K RDNT no 10-K REGN 0 vs 0 RGEN no 10-K RMD 0 vs 0 ROIV no 10-K RPRX no 10-K RVMD no 10-K RVTY 0 vs 0 RXRX no 10-K RYTM no 10-K SGRY no 10-K SHC no 10-K SMMT no 10-K SOLV 0 vs 0 SRPT no 10-K SRRK no 10-K STE 0 vs 0 SUPN no 10-K SYK 0 vs 0 TARS no 10-K TECH 0 vs 0 TEVA no 10-K TFX no 10-K TGTX no 10-K THC no 10-K TMDX no 10-K TMO 0 vs 0 TWST no 10-K UFPT no 10-K UHS 0 vs 0 UNH 0 vs 0 UTHR no 10-K VCEL no 10-K VCYT no 10-K VKTX no 10-K VRTX 0 vs 0 VTRS 0 vs 0 WAT 0 vs 0 WGS no 10-K WRBY no 10-K WST 0 vs 0 XENE no 10-K XRAY no 10-K ZBH 0 vs 0 ZLAB no 10-K ZTS 0 vs 0
3 · Quotes

What the companies wrote

The paragraphs themselves, as filed, each linked to its filing on sec.gov
6 of 76 shown

CI Cigna Group

1 paragraph

… other global organizations, where this individual defined information security strategies; built global information security programs; implemented cybersecurity capabilities that protect consumers, wholesale partners and brands; and oversaw the security of a global payment network, a corporate network and digital assets.

10-K, 10-K Feb 26, 2026 ↗

VEEV VEEVA SYSTEMS INC

1 paragraph

• Veeva PromoMats is an end-to-end content and digital asset management (“DAM”) solution through which life sciences companies can collaborate, review, distribute, and update commercial content and manage assets. PromoMats also includes integrated AI Agents that assist with document review.

10-K, 10-K Mar 20, 2026 ↗

A AGILENT TECHNOLOGIES, INC.

0 paragraphs

Not mentioned in the latest 10-K.

ABBV AbbVie Inc.

0 paragraphs

Not mentioned in the latest 10-K.

ABT ABBOTT LABORATORIES

0 paragraphs

Not mentioned in the latest 10-K.

ACAD ACADIA PHARMACEUTICALS INC

0 paragraphs

Not mentioned in the latest 10-K.

Show all 76 companies' quotes

ACHC Acadia Healthcare Company, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

ADMA ADMA BIOLOGICS, INC.

0 paragraphs

Not mentioned in the latest 10-K.

ADUS Addus HomeCare Corp

0 paragraphs

Not mentioned in the latest 10-K.

AGIO AGIOS PHARMACEUTICALS, INC.

0 paragraphs

Not mentioned in the latest 10-K.

ALGN ALIGN TECHNOLOGY INC

0 paragraphs

Not mentioned in the latest 10-K.

ALKS Alkermes plc.

0 paragraphs

Not mentioned in the latest 10-K.

ALNY ALNYLAM PHARMACEUTICALS, INC.

0 paragraphs

Not mentioned in the latest 10-K.

AMGN AMGEN INC

0 paragraphs

Not mentioned in the latest 10-K.

AMRX Amneal Pharmaceuticals, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

AXSM Axsome Therapeutics, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

BAX BAXTER INTERNATIONAL INC

0 paragraphs

Not mentioned in the latest 10-K.

BBIO BridgeBio Pharma, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

BCRX BIOCRYST PHARMACEUTICALS INC

0 paragraphs

Not mentioned in the latest 10-K.

BDX BECTON DICKINSON & CO

0 paragraphs

Not mentioned in the latest 10-K.

BEAM Beam Therapeutics Inc.

0 paragraphs

Not mentioned in the latest 10-K.

BHC Bausch Health Companies Inc.

0 paragraphs

Not mentioned in the latest 10-K.

BIIB BIOGEN INC.

0 paragraphs

Not mentioned in the latest 10-K.

BKD Brookdale Senior Living Inc.

0 paragraphs

Not mentioned in the latest 10-K.

BMRN BIOMARIN PHARMACEUTICAL INC

0 paragraphs

Not mentioned in the latest 10-K.

BMY BRISTOL MYERS SQUIBB CO

0 paragraphs

Not mentioned in the latest 10-K.

BSX BOSTON SCIENTIFIC CORP

0 paragraphs

Not mentioned in the latest 10-K.

BTSG BrightSpring Health Services, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

CAH CARDINAL HEALTH INC

0 paragraphs

Not mentioned in the latest 10-K.

CNC CENTENE CORP

0 paragraphs

Not mentioned in the latest 10-K.

COO COOPER COMPANIES, INC.

0 paragraphs

Not mentioned in the latest 10-K.

COR Cencora, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

0 paragraphs

Not mentioned in the latest 10-K.

CVS CVS HEALTH Corp

0 paragraphs

Not mentioned in the latest 10-K.

DGX QUEST DIAGNOSTICS INC

0 paragraphs

Not mentioned in the latest 10-K.

DHR DANAHER CORP /DE/

0 paragraphs

Not mentioned in the latest 10-K.

DVA DAVITA INC.

0 paragraphs

Not mentioned in the latest 10-K.

DXCM DEXCOM INC

0 paragraphs

Not mentioned in the latest 10-K.

ELV Elevance Health, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

EW Edwards Lifesciences Corp

0 paragraphs

Not mentioned in the latest 10-K.

GEHC GE HealthCare Technologies Inc.

0 paragraphs

Not mentioned in the latest 10-K.

GILD GILEAD SCIENCES, INC.

0 paragraphs

Not mentioned in the latest 10-K.

HCA HCA Healthcare, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

HSIC HENRY SCHEIN INC

0 paragraphs

Not mentioned in the latest 10-K.

HUM HUMANA INC

0 paragraphs

Not mentioned in the latest 10-K.

IDXX IDEXX LABORATORIES INC /DE

0 paragraphs

Not mentioned in the latest 10-K.

ILMN ILLUMINA, INC.

0 paragraphs

Not mentioned in the latest 10-K.

INCY INCYTE CORP

0 paragraphs

Not mentioned in the latest 10-K.

IQV IQVIA HOLDINGS INC.

0 paragraphs

Not mentioned in the latest 10-K.

ISRG INTUITIVE SURGICAL INC

0 paragraphs

Not mentioned in the latest 10-K.

JNJ JOHNSON & JOHNSON

0 paragraphs

Not mentioned in the latest 10-K.

LH LABCORP HOLDINGS INC.

0 paragraphs

Not mentioned in the latest 10-K.

LLY ELI LILLY & Co

0 paragraphs

Not mentioned in the latest 10-K.

MCK MCKESSON CORP

0 paragraphs

Not mentioned in the latest 10-K.

MDT Medtronic plc

0 paragraphs

Not mentioned in the latest 10-K.

MRK Merck & Co., Inc.

0 paragraphs

Not mentioned in the latest 10-K.

MRNA Moderna, Inc.

0 paragraphs

Not mentioned in the latest 10-K.

MTD METTLER TOLEDO INTERNATIONAL INC/

0 paragraphs

Not mentioned in the latest 10-K.

PFE PFIZER INC

0 paragraphs

Not mentioned in the latest 10-K.

PODD INSULET CORP

0 paragraphs

Not mentioned in the latest 10-K.

REGN REGENERON PHARMACEUTICALS, INC.

0 paragraphs

Not mentioned in the latest 10-K.

RMD RESMED INC

0 paragraphs

Not mentioned in the latest 10-K.

RVTY REVVITY, INC.

0 paragraphs

Not mentioned in the latest 10-K.

SOLV Solventum Corp

0 paragraphs

Not mentioned in the latest 10-K.

STE STERIS plc

0 paragraphs

Not mentioned in the latest 10-K.

SYK STRYKER CORP

0 paragraphs

Not mentioned in the latest 10-K.

TECH BIO-TECHNE Corp

0 paragraphs

Not mentioned in the latest 10-K.

TMO THERMO FISHER SCIENTIFIC INC.

0 paragraphs

Not mentioned in the latest 10-K.

UHS UNIVERSAL HEALTH SERVICES INC

0 paragraphs

Not mentioned in the latest 10-K.

UNH UNITEDHEALTH GROUP INC

0 paragraphs

Not mentioned in the latest 10-K.

VRTX VERTEX PHARMACEUTICALS INC / MA

0 paragraphs

Not mentioned in the latest 10-K.

VTRS Viatris Inc

0 paragraphs

Not mentioned in the latest 10-K.

WAT WATERS CORP /DE/

0 paragraphs

Not mentioned in the latest 10-K.

WST WEST PHARMACEUTICAL SERVICES INC

0 paragraphs

Not mentioned in the latest 10-K.

ZBH ZIMMER BIOMET HOLDINGS, INC.

0 paragraphs

Not mentioned in the latest 10-K.

ZTS Zoetis Inc.

0 paragraphs

Not mentioned in the latest 10-K.